Boston Scientific (BSP:B1SX34) EPS (Basic): R$12.89 (TTM As of Mar. 2026)


BSP:B1SX34 Boston Scientific Corp BSP:B1SX34
78 GF Score
Price R$233.45
GF Value R$530.10
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific EPS (Basic)?

Boston Scientific BSP:B1SX34 +1.81% 78 EPS (Basic) is R$12.89 as of Mar. 2026. GuruFocus rates BSP:B1SX34 with a GF Score™ of 78/100 and a GF Value™ of R$530.10 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Boston Scientific's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was R$4.71. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was R$12.89.

Boston Scientific's EPS (Diluted) for the three months ended in Mar. 2026 was R$4.71. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was R$12.84.

Boston Scientific's EPS without NRI for the three months ended in Mar. 2026 was R$4.18. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 16.73.

During the past 12 months, Boston Scientific's average EPS without NRIGrowth Rate was 14.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 21.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 23.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Boston Scientific's highest 3-Year average EPS without NRI Growth Rate was 123.60% per year. The lowest was -70.30% per year. And the median was 16.20% per year.

Boston Scientific  (BSP:B1SX34) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Boston Scientific EPS (Basic) Related Terms

Boston Scientific EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Boston Scientific's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific EPS (Basic) Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.90 2.36 5.29 7.69 10.69

Boston Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.65 3.00 2.74 2.46 4.71
BSP:B1SX34
78GF Score
Boston Scientific Corp BSP:B1SX34
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Boston Scientific's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(15810.619-0)/1480.400
=10.68

Boston Scientific's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(7012.894-0)/1484.900
=4.72

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$12.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of R$12.89 mean?
Boston Scientific (BSP:B1SX34) has a EPS (Basic) of R$12.89 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's EPS (Basic) too high?
Boston Scientific's current EPS (Basic) is R$12.89. Overall, Boston Scientific has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's EPS (Basic) compare to EW and MDT?
Boston Scientific's EPS (Basic) of R$12.89 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Boston Scientific and its competitors. Boston Scientific's current EPS (Basic) is R$12.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (BSP:B1SX34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$530.10, compared to a current price of R$233.45 — trading 56% below its estimated fair value. The current EPS (Basic) is R$12.89. Boston Scientific's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Boston Scientific (BSP:B1SX34), the current EPS (Basic) is R$12.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (BSP:B1SX34) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of R$233.45 is trading 56% below its estimated GF Value™ of R$530.10. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for BSP:B1SX34:

  • EPS (Basic): R$12.89
  • GF Value™: R$530.10 vs. price of R$233.45 (56% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the BSP:B1SX34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
78GF Score

Get the complete analysis for BSP:B1SX34

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$233.45
Price
R$530.10
GF Value